menu
    • menu
    [{"orgOrder":0,"company":"NorthX Biologics","sponsor":"Amarna Therapeutics","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Cell & Gene Therapy","year":"2025","type":"Agreement","leadProduct":"Nimvec AM510","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Preclinical","graph3":"NorthX Biologics","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"NorthX Biologics \/ Amarna Therapeutics","highestDevelopmentStatusID":"4","companyTruncated":"NorthX Biologics \/ Amarna Therapeutics"}]

    Find Clinical Drug Pipeline Developments & Deals by NorthX Biologics

    Menu

    NorthX Biologics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    SERVICES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            NorthX Biologics

                            Sweden arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            NorthX Biologics

                            Sweden arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Nimvec AM510

                            Therapeutic Area : Endocrinology

                            Study Phase : Preclinical

                            Sponsor : Amarna Therapeutics

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            DEALS_DEV arrow-down

                            Amarna and NorthX Finalize Agreement to Advance Nimvec™ AM510 Gene Therapy

                            Details : Under the terms of the agreement, Amarna enables the transfer & optimization of Amarna’s research-scale production process for Nimvec AM510 to NorthX. It is being evaluated for Type 1 Diabetes.

                            Product Name : Nimvec AM510

                            Product Type : Cell & Gene Therapy

                            Upfront Cash : Undisclosed

                            July 08, 2025

                            Lead Product(s) : Nimvec AM510

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Preclinical

                            Sponsor : Amarna Therapeutics

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth